The #FDA approved the first oral GLP-1 receptor agonist, semaglutide (#Wegovy pill), for chronic weight management in adults with obesity or overweight with comorbidities, offering a noninjectable alternative with significant weight loss benefits
So for the time being, it might be hard to get hold of
The STEP 1 trial extension study, published in Diabetes, Obesity and Metabolism , found that participants who discontinued semaglutide after 68 weeks regained approximately two-thirds of their lost weight within one year of stopping treatment
Meanwhile, you are watching the scale drop and wondering if you will spend the rest of your life with a weekly injection
Semaglutide tablets significantly reduced the occurrence of MACE
Nausea management protocol Start implementing these strategies before your first injection, not after nausea hits: Meal sizing: Cut portions by 30 to 50% from day one